{"id":5857,"date":"2026-07-13T16:07:36","date_gmt":"2026-07-13T14:07:36","guid":{"rendered":"https:\/\/buw-engineering.com\/medical-technology-as-a-driver-of-efficiency-in-the-healthcare-system\/"},"modified":"2026-07-13T16:14:44","modified_gmt":"2026-07-13T14:14:44","slug":"medical-technology-as-a-driver-of-efficiency-in-the-healthcare-system","status":"publish","type":"post","link":"https:\/\/buw-engineering.com\/en\/medical-technology-as-a-driver-of-efficiency-in-the-healthcare-system\/","title":{"rendered":"Medical Technology as a Driver of Efficiency in the Healthcare System"},"content":{"rendered":"
The Prognos study \u201cEfficiency Potential of Innovations for the Healthcare Sector<\/a>\u201d estimates the annual savings potential resulting from innovations in the industrial healthcare sector at over 20.8 billion euros in the statutory health insurance system. Approximately 9 billion euros of this amount is attributable to medical technology. We\u2019ll briefly outline for you the resulting requirements for engineering, verification, and industrialization.<\/h5>\n<\/div><\/div>
<\/div>
\n

Efficiency in the healthcare system is achieved when medical devices function properly in hospitals, during outpatient procedures, and for home use.<\/p>\n<\/blockquote>\n<\/div><\/div>

<\/div>

Efficiency in the healthcare system is achieved when medical devices function properly in hospitals, during outpatient procedures, and for home use.<\/p>\n

Prognos estimates that innovations in the industrial healthcare sector currently offer annual savings potential of over 20.8 billion euros in the statutory health insurance (GKV) system. About 9 billion euros of this amount is attributable to medical technology. A particularly significant driver of savings lies in the shift toward outpatient care, for which the study cites a potential of 6.02 billion euros per year. In the \u201cPriority for Innovation and Digitalization\u201d scenario, statutory health insurance benefit expenditures rise to 616 billion euros by 2045, rather than 663 billion euros in the reference scenario. The premium rate would then be 18.7 percent instead of 20.1 percent. These figures are based on specific technical decisions.<\/p>\n<\/div><\/div>

<\/div>
\n

A medical device doesn’t save money just because it’s new.<\/p>\n<\/blockquote>\n<\/div><\/div>

It proves its value when it works in a clinical setting, can be operated properly, can be reliably tested, has been designed with regulatory compliance in mind, and remains stable in mass production.<\/p>\n<\/div><\/div>

<\/div>